News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24
Photo taken from Agenus/LinkedIn
Sep 15, 2024, 00:29

Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24

Agenus shared on LinkedIn:

“Breelyn Wilky, presented new data at ESMO24 highlighting the potential of our investigational immunotherapy combination, botensilimab and balstilimab, for treating patients with refractory sarcomas.

Learn more about this advancement.”

Source: Agenus/LinkedIn

Agenus Balstilimab botensilimab Breelyn Wilky cancer ESMO ESMO24 immunotherapy OncoDaily Oncology refractory sarcomas sarcomas
Special Coverage
Science
Jan 14, 2025, 19:05
Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer
Societies
Jan 14, 2025, 19:03
Become a CancerX 2025 Accelerator Mentor
Blog
Jan 14, 2025, 18:58
Professor Tak Mak shares the story behind his discovery of the T Cell Receptor - SPCC
Science
Jan 14, 2025, 18:51
Abi Siva: Another step close to De-escalation
Science
Jan 14, 2025, 18:49
Naveen Pemmaraju: Addition of navitoclax to ruxolitinib for patients with myelofibrosis
Blog
Jan 14, 2025, 18:47
Zeena Salman: Five-year anniversary working with St. Jude Children's Research Hospital
Dialogues
Jan 14, 2025, 18:45
United by Unique: Centering Care Around People and Their Stories
Blog
Jan 14, 2025, 18:40
Anna Rathkopf: Learning about Breast Density after a cancer diagnosis
Blog
Jan 14, 2025, 18:40
GSK has announced agreement to acquire the U.S. biotech firm IDRx for up to $1.15 billion
Blog
Jan 14, 2025, 18:30
Keynote Lecture by Pamela Kunz to Highlight Need for Inclusive Science in GI Cancers - ASCO
Blog
Jan 14, 2025, 18:21
Applications are open for the LUNGevity Research Awards
Insight
Jan 14, 2025, 18:15
James Crowley: ctDNA Origins, Cancer Biology and Clinical Study Needs